Nutritional Foundation Begin transitioning to a protein-forward, moderate-calorie diet at least one to two weeks before starting therapy
Rather than morning administration competing with the growth hormone peak stimulated by secretagogues (often administered at night), AOD-9604 moves to morning while CJC-1295/Ipamorelin administers before bed
Just gotta show some patience and stick it out
AOD 9604 peptide is a fat-burning peptide that can help combat obesity
The enzyme plays a crucial role in the production of red blood cells, the functioning of the nervous system, and the synthesis of DNA
Its main effects include: Increasing lipolysis (fat breakdown) Reducing lipogenesis (fat storage) Improving fat metabolism signaling Doing so without affecting muscle, bone, or glucose regulation Importantly: It does not stimulate growth hormone release It does not rely on pituitary feedback loops It does not act on central appetite pathways This is why it has such a clean safety profile